World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
97
Citations
28744
World Ranking
488
National Ranking
227

David S. Perlin publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where David S. Perlin sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 339 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

David S. Perlin D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where David S. Perlin sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 97 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

David S. Perlin is affiliated with Rutgers, The State University of New Jersey in the United States. Their research primarily focuses on medicine, with a specialization in infectious diseases and a considerable emphasis on antifungal resistance and susceptibility. Their work covers several subfields, including epidemiology, molecular biology, pharmacology, and plant science.

The scientist's frequent research topics include:

  • Antifungal resistance and susceptibility
  • Fungal infections and studies
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Antimicrobial resistance in Staphylococcus
  • Fungal and yeast genetics research
  • Infectious diseases and mycology
  • Plant pathogens and fungal diseases

David S. Perlin has published extensively in notable venues. Common publication forums include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Fungi
  • Antimicrobial Agents and Chemotherapy
  • Medical Mycology
  • Studies in Mycology

Their collaborations often involve several recurrent coauthors, such as:

  • Amir Arastehfar
  • Erika Shor
  • Macit İlkit
  • Farnaz Daneshnia
  • Rocio Garcia-Rubio

Among recent publications by or involving David S. Perlin are the following works:

  • COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment, 2020, Journal of Fungi
  • Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium, 2020, Antibiotics
  • A naturally inspired antibiotic to target multidrug-resistant pathogens, 2022, Nature
  • Aspergillus fumigatus and aspergillosis: From basics to clinics, 2021, Studies in Mycology
  • Studying severe long COVID to understand post-infectious disorders beyond COVID-19, 2022, Nature Medicine

The concentration of David S. Perlin's work aligns closely with topics in infectious diseases, fungal biology, and antimicrobial resistance, drawing on multidisciplinary approaches that span clinical and molecular studies. Their scholarship contributes to understanding both fungal pathogens and broader antimicrobial resistance mechanisms.

Best Publications

  • The global problem of antifungal resistance: prevalence, mechanisms, and management

    David S Perlin;Riina Rautemaa-Richardson;Ana Alastruey-Izquierdo

  • Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

    Barbara D. Alexander;Melissa D. Johnson;Christopher D. Pfeiffer;Cristina Jiménez-Ortigosa

  • Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure

    Susan J. Howard;Dasa Cerar;Michael J. Anderson;Ahmed Albarrag

  • Resistance to echinocandin-class antifungal drugs

    David S. Perlin

  • Mechanisms of Antifungal Drug Resistance

    Leah E. Cowen;Dominique Sanglard;Susan J. Howard;P. David Rogers

  • A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.

    Anuradha Chowdhary;Anupam Prakash;Cheshta Sharma;Milena Kordalewska

  • Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates

    S. Park;R. Kelly;J. Nielsen Kahn;J. Robles

  • Culture-independent discovery of the malacidins as calcium-dependent antibiotics with activity against multidrug-resistant Gram-positive pathogens.

    Bradley M. Hover;Seong Hwan Kim;Micah Katz;Zachary Charlop-Powers

  • A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.

    Guillermo Garcia-Effron;Santosh K. Katiyar;Steven Park;Thomas D. Edlind

  • COVID-19 associated pulmonary aspergillosis (CAPA)—from immunology to treatment

    Amir Arastehfar;Agostinho Carvalho;Frank L. van de Veerdonk;Jeffrey D. Jenks

  • High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal Disease

    David W. Denning;Steven Park;Cornelia Lass-Florl;Marcin G. Fraczek;Marcin G. Fraczek

  • Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria

    M.A. Pfaller;D.J. Diekema;D. Andes;M.C. Arendrup

  • Echinocandin Resistance in Candida

    David S. Perlin

  • Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-d-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint

    Guillermo Garcia-Effron;Samuel Lee;Steven Park;John D. Cleary

  • Echinocandin resistance: an emerging clinical problem?

    Maiken Cavling Arendrup;David S. Perlin

  • Mechanisms of echinocandin antifungal drug resistance.

    David S. Perlin

  • Current perspectives on echinocandin class drugs

    David S Perlin

  • Multiple Resistance Mechanisms among Aspergillus fumigatus Mutants with High-Level Resistance to Itraconazole

    Adriana M. Nascimento;Gustavo H. Goldman;Steven Park;Salvatore A. E. Marras

  • Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints.

    Guillermo Garcia-Effron;Steven Park;David S. Perlin

  • A naturally inspired antibiotic to target multidrug-resistant pathogens

    Unknown

  • Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance.

    Kelley R. Healey;Yanan Zhao;Winder B. Perez;Shawn R. Lockhart

  • Assessing Resistance to the Echinocandin Antifungal Drug Caspofungin in Candida albicans by Profiling Mutations in FKS1

    Sergey V. Balashov;Steven Park;David S. Perlin;David S. Perlin

Frequent Co-Authors

Steven Park
Steven Park Rutgers, The State University of New Jersey
Guillermo Garcia-Effron
Guillermo Garcia-Effron National University of the Littoral
Maiken Cavling Arendrup
Maiken Cavling Arendrup Statens Serum Institut
James E. Haber
James E. Haber Brandeis University
Thomas J. Walsh
Thomas J. Walsh Weill Cornell Medicine
Dimitrios P. Kontoyiannis
Dimitrios P. Kontoyiannis The University of Texas MD Anderson Cancer Center
David W. Denning
David W. Denning University of Manchester
Macit Ilkit
Macit Ilkit Cukurova University
Teun Boekhout
Teun Boekhout University of Amsterdam
Emmanuel Roilides
Emmanuel Roilides Aristotle University of Thessaloniki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to a variety of career pathways, many of which can be enhanced through complementary online degrees. For individuals seeking accessible education options, especially those looking for degrees for felons, online programs provide flexible and supportive environments to re-enter the workforce.

Healthcare roles are closely tied to microbiology expertise. For example, becoming a functional medicine nurse practitioner offers a blend of clinical skills with a focus on holistic patient care. Interested candidates can explore the functional medicine np salary to understand the financial and professional rewards of this career path.

Additionally, certifications like the CPC certification can broaden opportunities in health services by enabling careers in medical coding and billing, vital sectors that support healthcare data management efficiently and accurately.

Another promising avenue is health information management, which merges technology with healthcare. By reviewing health information management salary trends, prospective students can gauge the potential benefits of entering this field, where managing patient data and ensuring compliance are critical roles.

Overall, combining microbiology knowledge with these related disciplines can significantly enhance employability and career growth in the health and science sectors.

Best Scientists Citing David S. Perlin

Trending Scientists

Recently Published Articles